BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25585874)

  • 1. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
    Zangenberg M; Grubach L; Aggerholm A; Silkjaer T; Juhl-Christensen C; Nyvold CG; Kjeldsen E; Ommen HB; Hokland P
    Eur J Haematol; 2009 Nov; 83(5):439-48. PubMed ID: 19563517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
    Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
    Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.
    Haferlach C; Mecucci C; Schnittger S; Kohlmann A; Mancini M; Cuneo A; Testoni N; Rege-Cambrin G; Santucci A; Vignetti M; Fazi P; Martelli MP; Haferlach T; Falini B
    Blood; 2009 Oct; 114(14):3024-32. PubMed ID: 19429869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia.
    Grubach L; Juhl-Christensen C; Rethmeier A; Olesen LH; Aggerholm A; Hokland P; Ostergaard M
    Eur J Haematol; 2008 Aug; 81(2):112-22. PubMed ID: 18410541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of HOXA5 hypermethylation in acute myeloid leukemia is associated with short-term outcome.
    Kim SY; Hwang SH; Song EJ; Shin HJ; Jung JS; Lee EY
    Korean J Lab Med; 2010 Oct; 30(5):469-73. PubMed ID: 20890077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
    Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
    Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
    Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
    Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Met inhibition in a HOXA9/Meis1 model of CN-AML.
    Mulgrew NM; Kettyle LM; Ramsey JM; Cull S; Smyth LJ; Mervyn DM; Bijl JJ; Thompson A
    Dev Dyn; 2014 Jan; 243(1):172-81. PubMed ID: 24307265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia.
    Musialik E; Bujko M; Kober P; Wypych A; Gawle-Krawczyk K; Matysiak M; Siedlecki JA
    Blood Res; 2015 Mar; 50(1):26-32. PubMed ID: 25830127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
    Jia JS; Spicuglia S
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3835-40. PubMed ID: 24548444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.
    Itonaga H; Imanishi D; Wong YF; Sato S; Ando K; Sawayama Y; Sasaki D; Tsuruda K; Hasegawa H; Imaizumi Y; Taguchi J; Tsushima H; Yoshida S; Fukushima T; Hata T; Moriuchi Y; Yanagihara K; Miyazaki Y
    Leukemia; 2014 Jul; 28(7):1459-66. PubMed ID: 24457336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
    Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
    Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.